Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 1
1985 3
1986 2
1987 3
1988 2
1989 3
1990 3
1991 2
1992 2
1993 2
1994 1
1995 2
1996 1
1997 1
1998 2
1999 2
2000 3
2001 2
2002 2
2003 1
2004 3
2005 5
2006 4
2007 5
2008 6
2009 6
2010 1
2011 8
2012 8
2013 4
2014 4
2015 3
2016 5
2017 6
2018 4
2021 3
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 22275160

110 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and tolerability of a selective alpha(2C)-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: a single-center, double-blind, placebo-controlled, randomized crossover study.
Wise RA, Wigley FM, White B, Leatherman G, Zhong J, Krasa H, Kambayashi J, Orlandi C, Czerwiec FS. Wise RA, et al. Arthritis Rheum. 2004 Dec;50(12):3994-4001. doi: 10.1002/art.20665. Arthritis Rheum. 2004. PMID: 15593189 Free article. Clinical Trial.
A double-blind, randomized, placebo-controlled crossover trial of the α2C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis.
Herrick AL, Murray AK, Ruck A, Rouru J, Moore TL, Whiteside J, Hakulinen P, Wigley F, Snapir A. Herrick AL, et al. Rheumatology (Oxford). 2014 May;53(5):948-52. doi: 10.1093/rheumatology/ket421. Epub 2014 Jan 31. Rheumatology (Oxford). 2014. PMID: 24489014 Clinical Trial.
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
Wigley FM, Korn JH, Csuka ME, Medsger TA Jr, Rothfield NF, Ellman M, Martin R, Collier DH, Weinstein A, Furst DE, Jimenez SA, Mayes MD, Merkel PA, Gruber B, Kaufman L, Varga J, Bell P, Kern J, Marrott P, White B, Simms RW, Phillips AC, Seibold JR. Wigley FM, et al. Arthritis Rheum. 1998 Apr;41(4):670-7. doi: 10.1002/1529-0131(199804)41:4<670::AID-ART14>3.0.CO;2-I. Arthritis Rheum. 1998. PMID: 9550476 Clinical Trial.
110 results